The Department of Veterans Affairs (VA) Consolidated Mail Outpatient Pharmacy (CMOP) has issued a Request for Information (RFI) to identify domestic small and large business pharmaceutical manufacturers. This RFI, designated 36C77026Q0061, is for market research and procurement planning purposes only and does not constitute a solicitation for a contract. The VA is seeking information on manufacturers of pharmaceuticals and ancillary items to support CMOP's Open Market (OM) purchases, which supplement their Prime Vendor contract. The scope includes items under NAICS codes 325412 (Pharmaceutical Preparation Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing). Interested manufacturers are requested to submit company, product, operational capability, and contracting information by March 15, 2026, at 4:30 PM CT, demonstrating compliance with federal, state, and local regulations and the capacity to support seven CMOP sites.

The document outlines requirements for the acquisition planning of commercially available pharmaceutical items. It details specific information required for each pharmaceutical product, including active ingredients, generic name, manufacturer specifics (name, generic drug name), FDA Approved NDC(s) #, FDA Approval #, certification of regulatory compliance, physical address of manufacturing facility, manufacturing capacity, and treatment usage. The request emphasizes that only NDCs with FDA approval should be submitted and must be reflective of the manufacturer, not a repackager. Additional information sought includes existing agency-wide contracts, frequency of stockouts, SAM UEI #, commercial entities where products are sold, average commercial cost per pill, and authorized distributors with state licenses and socio-economic status. A comprehensive list of pharmaceutical products with their descriptions and treatment usages is also provided, ranging from various medications (e.g., ABALOPARATIDE, ACAMPROSATE CA, IBUPROFEN) to medical supplies (e.g., BREAST MILK STORAGE BAGS, CATH SETS). The document underscores the need for fair and reasonable pricing for these open market items.